Successful Slow Desensitization to Tocilizumab in a 15-Year-Old Patient

J Investig Allergol Clin Immunol. 2018 Dec;28(6):436-438. doi: 10.18176/jiaci.0314.

Authors

M Cansever¹, N Şahin², I Dursun², C Geyik³, R Düşünsel², F Bektaş Kut¹, F Tahan¹

Affiliations

¹ Erciyes University, School of Medicine, Department of Pediatrics, Division of Allergy, Kayseri, Turkey.
² Erciyes University, School of Medicine, Department of Pediatrics, Division of Rheumatology, Kayseri, Turkey.
³ Erciyes University, School of Medicine, Department of Pediatrics, Kayseri, Turkey.

PMID: 30530397
DOI: 10.18176/jiaci.0314

No abstract available

Keywords: Allergic reactions; Anaphylaxis; Desensitization; Juvenile idiopathic arthritis; Tocilizumab.

MeSH terms

Adolescent
Antibodies, Monoclonal, Humanized / adverse effects*
Antibodies, Monoclonal, Humanized / therapeutic use
Arthritis, Juvenile / drug therapy
Desensitization, Immunologic / methods
Humans
Male

Substances

Antibodies, Monoclonal, Humanized
tocilizumab

Supplementary concepts

Rheumatoid Arthritis, Systemic Juvenile